Pravastatin and the Development of Diabetes Mellitus
Top Cited Papers
- 23 January 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (3) , 357-362
- https://doi.org/10.1161/01.cir.103.3.357
Abstract
Background—We examined the development of new diabetes mellitus in men aged 45 to 64 years during the West of Scotland Coronary Prevention Study. Methods and Results—Our definition of diabetes mell...Keywords
This publication has 20 references indexed in Scilit:
- The design of a prospective study of pravastatin in the elderly at risk (PROSPER)The American Journal of Cardiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatinAtherosclerosis, 1997
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Screening experience and baseline characteristics in the West of Scotland coronary prevention studyThe American Journal of Cardiology, 1995
- Effects of endotoxin and cytokines on lipid metabolismCurrent Opinion in Lipidology, 1994
- Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemiaAmerican Heart Journal, 1994
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993